Point72 Asset Management’s BioXcel Therapeutics BTAI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | – | Sell |
-167
| Closed | -$6.75K | – | 1450 |
|
|
2023
Q3 | $6.75K | Sell |
167
-14,955
| -99% | -$605K | ﹤0.01% | 1659 |
|
|
2023
Q2 | $1.61M | Buy |
+15,122
| New | +$1.61M | ﹤0.01% | 821 |
|
|
2022
Q2 | – | Sell |
-5,056
| Closed | -$1.69M | – | 1060 |
|
|
2022
Q1 | $1.69M | Buy |
+5,056
| New | +$1.69M | 0.01% | 818 |
|
|
2020
Q1 | – | Sell |
-15,938
| Closed | -$3.73M | – | 760 |
|
|
2019
Q4 | $3.73M | Buy |
15,938
+2,813
| +21% | +$658K | 0.02% | 499 |
|
|
2019
Q3 | $1.48M | Buy |
+13,125
| New | +$1.48M | 0.01% | 577 |
|
|
2018
Q4 | – | Sell |
-1,191
| Closed | -$146K | – | 864 |
|
|
2018
Q3 | $146K | Sell |
1,191
-2,922
| -71% | -$358K | ﹤0.01% | 801 |
|
|
2018
Q2 | $605K | Buy |
4,113
+397
| +11% | +$58.4K | ﹤0.01% | 705 |
|
|
2018
Q1 | $609K | Buy |
+3,716
| New | +$609K | ﹤0.01% | 699 |
|